Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04604002 · ClinicalTrials.gov registry record
Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 86
- Enrollment target
NCT04604002: Completed study, sponsored by Heidelberg Engineering.
NCT04604002 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04604002 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations
Primary Outcome
Graded 0-2 (0 = poor, 1 = average, 2 = good)
Interventions
- DEVICE Optical Coherence Tomography
- DEVICE OCT Angiography
- DEVICE Color Fundus Photography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2022-01-04 |
What the finished NCT04604002 record still lists
NCT04604002 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Optical Coherence Tomography is the first listed.
NCT04604002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04604002 about?
NCT04604002 is a clinical study titled "Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types". Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations
What is the current status of trial NCT04604002?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2020-10-15. Estimated completion is 2022-01-04.
What interventions are being tested in trial NCT04604002?
The interventions under investigation include: Optical Coherence Tomography (DEVICE), OCT Angiography (DEVICE), Color Fundus Photography (DEVICE).
Who is sponsoring clinical trial NCT04604002?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI